Viemed Healthcare (VMD) Stock Price, News & Analysis

Company Overview

Viemed Healthcare, Inc. (NASDAQ: VMD) is a healthcare services company that provides in-home medical equipment and clinical support for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home, reduce avoidable hospitalizations and support ongoing disease management.

The company’s offerings include non-invasive ventilation, oxygen therapy, sleep-apnea treatment and related respiratory equipment. Viemed also provides clinical services such as respiratory therapy, patient education, remote monitoring and other home-based care programs. Its solutions primarily support patients with conditions including chronic obstructive pulmonary disease, neuromuscular disease and other causes of chronic respiratory failure.

Viemed was founded in 2006 and has expanded its home-based care platform across the United States. The company is headquartered in Lafayette, Louisiana, and serves patients through a nationwide network of respiratory therapists, nurses and other healthcare professionals. Casey Hoyt serves as chief executive officer, while co-founder Michael Moore has held a senior leadership role with the company.

Key Stats

• Today's Range: $8.71 to $8.93
• 50-Day Range: $8.57 to $12.12
• 52-Week Range: $6.05 to $12.61
• Volume: 199,815 shs
• Average Volume: 261,829 shs
• Market Capitalization: $339.36 million
• P/E Ratio: 24.75
• Dividend Yield: N/A
• Price Target: $14.00
• Consensus Rating: Hold

Viemed Healthcare Stock Analysis - MarketRank™

Viemed Healthcare scored higher than 87% of companies evaluated by MarketBeat, and ranked 58th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Hold

Consensus Rating

Viemed Healthcare has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and no sell ratings.

Upside Potential

Viemed Healthcare has a consensus price target of $14.00, representing about 57.1% upside from its current price of $8.91.

Amount of Analyst Coverage

Viemed Healthcare has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 17.07%

Earnings Growth

Earnings for Viemed Healthcare are expected to grow by 17.07% in the coming year, from $0.41 to $0.48 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Viemed Healthcare is 24.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.64.

Price to Earnings Ratio vs. Sector

The P/E ratio of Viemed Healthcare is 24.75, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.82.

Price to Earnings Growth Ratio

Viemed Healthcare has a PEG Ratio of 2.20. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Viemed Healthcare has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.38% of the float of Viemed Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Viemed Healthcare has a short interest ratio ("days to cover") of 5.24.

Change versus previous month

Short interest in Viemed Healthcare has recently increased by 9.65%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Viemed Healthcare does not currently pay a dividend.

Dividend Growth

Viemed Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: N/A

News Sentiment

Viemed Healthcare has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Viemed Healthcare this week, compared to 1 article on an average week.

MarketBeat Follows

3 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Viemed Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.60% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/03/2026
• Today: 9/27/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:VMD
• CIK: 1729149
• Web: www.viemed.com
• Phone: (337) 504-3802
• Fax: N/A
• Employees: 1,382
• Year Founded: 2006

Price Target and Rating

• Average Price Target for Viemed Healthcare: $14.00
• High Price Target: $14.00
• Low Price Target: $14.00
• Potential Upside/Downside: +57.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.36
• Trailing P/E Ratio: 24.75
• Forward P/E Ratio: 21.73
• P/E Growth: 2.2
• Net Income: $14.93 million
• Net Margins: 4.81%
• Pretax Margin: 7.02%
• Return on Equity: 10.16%
• Return on Assets: 7.22%

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 1.13
• Quick Ratio: 1.02

Sales & Book Value

• Annual Sales: $301.61 million
• Price / Sales: 1.13
• Cash Flow: $1.15 per share
• Price / Cash Flow: 7.74
• Book Value: $3.78 per share
• Price / Book: 2.36

Miscellaneous

• Outstanding Shares: 38,088,000
• Free Float: 30,242,000
• Market Cap: $339.36 million
• Optionable: Not Optionable
• Beta: 1.09